NYSE:MD Pediatrix Medical Group (MD) Stock Price, News & Analysis $21.80 +0.27 (+1.23%) As of 01:07 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Pediatrix Medical Group Stock (NYSE:MD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MD alerts:Sign Up Key Stats Today's Range$21.20▼$21.8550-Day Range$19.71▼$23.9952-Week Range$11.84▼$24.99Volume997,844 shsAverage Volume901,962 shsMarket Capitalization$1.79 billionP/E Ratio10.55Dividend YieldN/APrice Target$22.50Consensus RatingHold Company Overview Pediatrix Medical Group, Inc. (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology. Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings. Pediatrix partners with hospitals, health systems and other healthcare providers across the United States to manage patient care programs, optimize clinical outcomes and support operational efficiencies. The company’s telehealth initiatives extend critical care expertise to remote and underserved locations while its research division advances evidence-based practices in neonatal and maternal-fetal medicine. Under the leadership of President and CEO David R. Anderson, Pediatrix Medical Group emphasizes clinical quality, patient safety and physician engagement. The group supports more than 3,500 physicians and advanced practice clinicians and collaborates with over 1,300 facilities nationwide. Pediatrix continues to invest in clinical education, data analytics and population health management to meet the evolving needs of mothers, newborns and pediatric patients.AI Generated. May Contain Errors. Read More Pediatrix Medical Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks48th Percentile Overall ScoreMD MarketRank™: Pediatrix Medical Group scored higher than 48% of companies evaluated by MarketBeat, and ranked 597th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingPediatrix Medical Group has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on no strong buy ratings, 1 buy rating, 5 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Pediatrix Medical Group is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoveragePediatrix Medical Group has only been the subject of 4 research reports in the past 90 days.Read more about Pediatrix Medical Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth0.48% Earnings GrowthEarnings for Pediatrix Medical Group are expected to grow by 0.48% in the coming year, from $2.08 to $2.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Pediatrix Medical Group is 10.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.27.Price to Earnings Ratio vs. SectorThe P/E ratio of Pediatrix Medical Group is 10.55, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 21.10.Price to Book Value per Share RatioPediatrix Medical Group has a P/B Ratio of 2.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Pediatrix Medical Group's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.29% of the float of Pediatrix Medical Group has been sold short.Short Interest Ratio / Days to CoverPediatrix Medical Group has a short interest ratio ("days to cover") of 3.17, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Pediatrix Medical Group has recently increased by 1.74%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPediatrix Medical Group does not currently pay a dividend.Dividend GrowthPediatrix Medical Group does not have a long track record of dividend growth. News and Social Media2.7 / 5News Sentiment0.38 News SentimentPediatrix Medical Group has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Pediatrix Medical Group this week, compared to 2 articles on an average week.Search InterestOnly 5 people have searched for MD on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows2 people have added Pediatrix Medical Group to their MarketBeat watchlist in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Pediatrix Medical Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $855,665.00 in company stock.Percentage Held by Insiders1.80% of the stock of Pediatrix Medical Group is held by insiders.Percentage Held by Institutions97.71% of the stock of Pediatrix Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Pediatrix Medical Group's insider trading history. Receive MD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MD Stock News HeadlinesQ1 earnings roundup: Pediatrix Medical Group (NYSE:MD) and the rest of the healthcare providers & services segmentJune 1 at 7:25 AM | msn.comAssessing Pediatrix Medical Group (MD) Valuation As Shares Show Mixed Short Term MomentumJune 1 at 7:25 AM | finance.yahoo.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.June 2 at 1:00 AM | Banyan Hill Publishing (Ad)Does Pediatrix Medical Group (MD) Stock Look Better After Q1 Report?May 28, 2026 | finance.yahoo.comCritical Analysis: Ethema Health (OTCMKTS:GRST) and Pediatrix Medical Group (NYSE:MD)May 27, 2026 | americanbankingnews.comVistagen Appoints Angel S. Angelov, MD, MBA, as Chief Medical OfficerMay 19, 2026 | businesswire.comPasskey Therapeutics Appoints Mandeep Kaur, MD, MS, as Chief Medical Officer to Advance Clinical Validation of Its Computational Genetics-Based Novel Drug Combination PlatformMay 19, 2026 | businesswire.comShirley Weis Sells 36,028 Shares of Pediatrix Medical Group (NYSE:MD) StockMay 15, 2026 | insidertrades.comSee More Headlines MD Stock Analysis - Frequently Asked Questions How have MD shares performed this year? Pediatrix Medical Group's stock was trading at $21.37 at the start of the year. Since then, MD stock has increased by 2.0% and is now trading at $21.7950. How were Pediatrix Medical Group's earnings last quarter? Pediatrix Medical Group, Inc. (NYSE:MD) posted its quarterly earnings data on Tuesday, May, 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.37 by $0.07. The company's quarterly revenue was up 3.9% compared to the same quarter last year. Read the conference call transcript. Who are Pediatrix Medical Group's major shareholders? Pediatrix Medical Group's top institutional investors include Dimensional Fund Advisors LP (4.64%), Wasatch Advisors LP (2.47%), Renaissance Technologies LLC (1.87%) and Allspring Global Investments Holdings LLC (1.17%). Insiders that own company stock include Mark S Ordan, C Marc Richards, James D Swift, Mary Ann E Moore, Michael A Rucker, Laura A Linynsky and Shirley A Weis. View institutional ownership trends. How do I buy shares of Pediatrix Medical Group? Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pediatrix Medical Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pediatrix Medical Group investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD). Company Calendar Last Earnings5/05/2026Today6/02/2026Next Earnings (Estimated)8/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 MD's financial health is in the Green zone, according to TradeSmith. MD has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical Services Sub-IndustryHealth Care Services Current SymbolNYSE:MD Previous SymbolNYSE:PDX CIK893949 Webwww.mednax.com Phone(954) 384-0175Fax954-838-9961Employees4,315Year Founded1979Price Target and Rating Average Price Target for Pediatrix Medical Group$22.50 High Price Target$27.00 Low Price Target$17.00 Potential Upside/Downside+3.2%Consensus RatingHold Rating Score (0-4)2.17 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)$2.06 Trailing P/E Ratio10.55 Forward P/E Ratio10.48 P/E GrowthN/ANet Income$165.39 million Net Margins9.02% Pretax Margin11.76% Return on Equity19.94% Return on Assets8.02% Debt Debt-to-Equity Ratio0.45 Current Ratio1.33 Quick Ratio1.33 Sales & Book Value Annual Sales$1.91 billion Price / Sales0.94 Cash Flow$2.26 per share Price / Cash Flow9.64 Book Value$10.08 per share Price / Book2.16Miscellaneous Outstanding Shares82,120,000Free Float80,644,000Market Cap$1.79 billion OptionableOptionable Beta0.69 Social Links The 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NYSE:MD) was last updated on 6/2/2026 by MarketBeat.com Staff. From Our PartnersPresident Trump just sparked a stock market MELT UPThe real reason Musk, Huang, Cook, and Fink just flew to Beijing Last week, the CEOs of Nvidia, Apple, Spac...Stansberry Research | SponsoredHow to claim a stake in SpaceX before the June 12 IPOSpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredElon Now Pays 15X More Than Your BankElon Musk's new bank is offering 6% interest per year - that's 15 times the national average of 0.4% that most...InvestorPlace | SponsoredGold hit $4,500 - but these miners haven't caught up yet$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...Golden Portfolio | SponsoredGiving “2022 pre-ChatGPT” vibes (but 10x bigger)When ChatGPT launched in 2022, Nvidia surged 1,800% over three years. Now, Nvidia's CEO suggests July 22nd cou...StocksToTrade | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
